Enlivex Therapeutics Ltd. - Ordinary Shares (ENLV)
1.0501
-0.0399 (-3.66%)
Enlivex Therapeutics Ltd is a biotechnology company focused on developing innovative therapies to harness the body’s immune system to treat a range of serious conditions
The company specializes in the research and development of cell therapy products aimed at modulating the immune response, particularly in the context of autoimmune diseases and other severe health conditions. With a commitment to advancing novel treatments, Enlivex aims to improve patient outcomes through its cutting-edge technological approaches and potential game-changing medical solutions.
| Date | Open | High | Low | Close | Volume | Adjusted Close |
|---|---|---|---|---|---|---|
| 2/10/2025 | 1.08 | 1.14 | 1.07 | 1.09 | 68,847 | 1.09 |
| 2/07/2025 | 1.01 | 1.12 | 1.00 | 1.10 | 30,530 | 1.10 |
| 2/06/2025 | 1.09 | 1.12 | 1.00 | 1.03 | 50,244 | 1.03 |
| 2/05/2025 | 1.11 | 1.14 | 1.07 | 1.10 | 53,853 | 1.10 |
| 2/04/2025 | 1.11 | 1.11 | 1.05 | 1.08 | 45,211 | 1.08 |
| 2/03/2025 | 1.06 | 1.09 | 1.00 | 1.08 | 48,350 | 1.08 |
| 1/31/2025 | 1.08 | 1.11 | 1.05 | 1.10 | 24,662 | 1.10 |
| 1/30/2025 | 1.10 | 1.12 | 1.06 | 1.11 | 47,891 | 1.11 |
| 1/29/2025 | 1.11 | 1.12 | 1.05 | 1.11 | 44,200 | 1.11 |
| 1/28/2025 | 1.14 | 1.15 | 1.08 | 1.13 | 35,968 | 1.13 |
| 1/27/2025 | 1.14 | 1.18 | 1.06 | 1.15 | 129,095 | 1.15 |
| 1/24/2025 | 1.18 | 1.19 | 1.16 | 1.18 | 49,290 | 1.18 |
| 1/23/2025 | 1.20 | 1.21 | 1.14 | 1.19 | 47,420 | 1.19 |
| 1/22/2025 | 1.20 | 1.20 | 1.17 | 1.19 | 30,215 | 1.19 |
| 1/21/2025 | 1.17 | 1.21 | 1.15 | 1.19 | 91,756 | 1.19 |
| 1/17/2025 | 1.16 | 1.17 | 1.12 | 1.13 | 45,575 | 1.13 |
| 1/16/2025 | 1.15 | 1.16 | 1.13 | 1.15 | 36,812 | 1.15 |
| 1/15/2025 | 1.14 | 1.15 | 1.13 | 1.15 | 93,267 | 1.15 |
| 1/14/2025 | 1.16 | 1.19 | 1.10 | 1.14 | 86,085 | 1.14 |
| 1/13/2025 | 1.15 | 1.17 | 1.13 | 1.15 | 60,970 | 1.15 |
| 1/10/2025 | 1.18 | 1.21 | 1.12 | 1.15 | 78,562 | 1.15 |
| 1/08/2025 | 1.23 | 1.23 | 1.15 | 1.18 | 108,432 | 1.18 |
| 1/07/2025 | 1.25 | 1.26 | 1.22 | 1.25 | 122,649 | 1.25 |
| 1/06/2025 | 1.23 | 1.25 | 1.19 | 1.23 | 111,755 | 1.23 |
| 1/03/2025 | 1.25 | 1.27 | 1.22 | 1.25 | 132,634 | 1.25 |
| 1/02/2025 | 1.20 | 1.25 | 1.19 | 1.24 | 94,288 | 1.24 |
| 12/31/2024 | 1.15 | 0.00 | 1.17 | 1.17 | 0 | 1.17 |
| 12/30/2024 | 1.15 | 1.20 | 1.13 | 1.15 | 129,010 | 1.15 |
| 12/27/2024 | 1.24 | 1.25 | 1.14 | 1.19 | 219,633 | 1.19 |
| 12/26/2024 | 1.23 | 1.25 | 1.22 | 1.25 | 101,317 | 1.25 |
| 12/24/2024 | 1.23 | 1.25 | 1.21 | 1.23 | 44,753 | 1.23 |
| 12/23/2024 | 1.20 | 1.26 | 1.20 | 1.24 | 99,358 | 1.24 |
| 12/20/2024 | 1.19 | 1.25 | 1.16 | 1.24 | 141,570 | 1.24 |
| 12/19/2024 | 1.20 | 1.22 | 1.16 | 1.19 | 61,496 | 1.19 |
| 12/18/2024 | 1.20 | 1.23 | 1.18 | 1.20 | 161,797 | 1.20 |
| 12/17/2024 | 1.15 | 1.24 | 1.13 | 1.18 | 219,651 | 1.18 |
| 12/16/2024 | 1.20 | 1.23 | 1.15 | 1.16 | 126,441 | 1.16 |
| 12/13/2024 | 1.22 | 1.23 | 1.15 | 1.20 | 122,913 | 1.20 |
| 12/12/2024 | 1.29 | 1.29 | 1.18 | 1.21 | 151,994 | 1.21 |
| 12/11/2024 | 1.25 | 1.29 | 1.22 | 1.26 | 209,418 | 1.26 |
| 12/10/2024 | 1.30 | 1.30 | 1.18 | 1.25 | 233,417 | 1.25 |
| 12/09/2024 | 1.28 | 1.29 | 1.23 | 1.28 | 213,049 | 1.28 |
| 12/06/2024 | 1.25 | 1.27 | 1.18 | 1.25 | 233,435 | 1.25 |
| 12/05/2024 | 1.31 | 1.34 | 1.20 | 1.22 | 310,827 | 1.22 |
| 12/04/2024 | 1.30 | 1.35 | 1.16 | 1.30 | 795,580 | 1.30 |
| 12/03/2024 | 1.22 | 1.32 | 1.10 | 1.30 | 4,523,311 | 1.30 |
| 12/02/2024 | 1.11 | 1.11 | 1.02 | 1.08 | 80,955 | 1.08 |
| 11/29/2024 | 1.17 | 1.17 | 1.10 | 1.14 | 30,821 | 1.14 |
| 11/27/2024 | 1.15 | 1.16 | 1.10 | 1.14 | 259,755 | 1.14 |
| 11/26/2024 | 1.08 | 1.09 | 1.01 | 1.07 | 133,705 | 1.07 |
| 11/25/2024 | 1.06 | 1.09 | 0.94 | 1.07 | 402,348 | 1.07 |
| 11/22/2024 | 0.83 | 0.93 | 0.83 | 0.93 | 221,613 | 0.93 |
| 11/21/2024 | 1.00 | 1.02 | 0.81 | 0.84 | 427,474 | 0.84 |
| 11/20/2024 | 1.06 | 1.11 | 0.93 | 0.98 | 388,174 | 0.98 |
| 11/19/2024 | 1.03 | 1.06 | 1.01 | 1.03 | 60,364 | 1.03 |
| 11/18/2024 | 1.06 | 1.08 | 0.99 | 1.05 | 198,590 | 1.05 |
| 11/15/2024 | 1.09 | 1.10 | 1.01 | 1.07 | 132,493 | 1.07 |
| 11/14/2024 | 1.16 | 1.17 | 1.07 | 1.08 | 158,628 | 1.08 |
| 11/13/2024 | 1.21 | 1.21 | 1.13 | 1.18 | 116,463 | 1.18 |
| 11/12/2024 | 1.20 | 1.23 | 1.17 | 1.20 | 115,147 | 1.20 |
| 11/11/2024 | 1.27 | 1.27 | 1.15 | 1.20 | 212,477 | 1.20 |